Literature DB >> 23263597

Time trends in incidence of Parkinson's disease diagnosis in UK primary care.

Laura Horsfall1, Irene Petersen, Kate Walters, Anette Schrag.   

Abstract

To examine time trends and the influence of socio-demographic and geographic factors on incidence of Parkinson's disease (PD) diagnosis in a large UK population-based cohort from The Health Improvement Network (THIN), a UK primary care database. All patients aged over 50 years and contributing data to THIN between January 1999 and December 2009 were extracted and the incidence rates of PD diagnoses were determined by age, gender, time period, social deprivation score and urban/rural status. The overall incidence of PD diagnosis for people over 50 years was 84 per 100,000 person years (95 % CI 82-85). After accounting for socio-demographic factors, the adjusted incidence rates in men were 46 % higher (95 % CI 43-48 %) than in women. Adjusted incidence rates were also 12 % higher in urban than rural areas (95 % CI 4-20 %) and slightly lower in less socially deprived areas. Over time there was a downward trend in PD diagnosis with the adjusted incidence rates declining by around 6 % every calendar year (95 % CI 5-6 %) between 1999 and 2009. Broadening the definition of PD from diagnostic codes to include symptoms and antiparkinsonian drug prescriptions increased the overall incidence to 118 per 100,000 person years (95 % CI 116-120) and showed a much weaker downward trend over time of around 1 % per calendar year (95 % CI 1-2 %). With the broader definition, the adjusted incidence rates remained significantly higher in men compared to women and in urban areas compared with rural areas but not in socially deprived areas. The PD diagnosis rates in the primary care setting were, as expected, higher in men, and slightly higher in urban areas, but not different between socio-economic groups. There was a decline in PD diagnosis in the primary care setting, which may largely represent changes in diagnosis and/or coding rather than a true decline in incidence.

Entities:  

Mesh:

Year:  2012        PMID: 23263597     DOI: 10.1007/s00415-012-6804-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Prevalence of Parkinson's disease in metropolitan and rural Queensland: a general practice survey.

Authors:  Catherine M Peters; Coral E Gartner; Peter A Silburn; George D Mellick
Journal:  J Clin Neurosci       Date:  2006-03-15       Impact factor: 1.961

2.  Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.

Authors:  D A van de Vijver; R A Roos; P A Jansen; A J Porsius; A de Boer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Oct-Nov       Impact factor: 2.890

3.  Time trends in the incidence of parkinsonism in Olmsted County, Minnesota.

Authors:  W A Rocca; J H Bower; S K McDonnell; B J Peterson; D M Maraganore
Journal:  Neurology       Date:  2001-08-14       Impact factor: 9.910

4.  Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.

Authors:  F D Dick; G De Palma; A Ahmadi; N W Scott; G J Prescott; J Bennett; S Semple; S Dick; C Counsell; P Mozzoni; N Haites; S Bezzina Wettinger; A Mutti; M Otelea; A Seaton; P Söderkvist; A Felice
Journal:  Occup Environ Med       Date:  2007-03-01       Impact factor: 4.402

5.  Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan.

Authors:  Chih Chuan Chen; Ta Fu Chen; Yuarn Chung Hwang; Ying Rong Wen; Yueh Hsia Chiu; Chia Yun Wu; Rong Chi Chen; John Jen Tai; Tony Hsiu Hsi Chen; Horng Huei Liou
Journal:  Neuroepidemiology       Date:  2009-11-04       Impact factor: 3.282

6.  Recent trends in the incidence of recorded depression in primary care.

Authors:  Greta Rait; Kate Walters; Mark Griffin; Marta Buszewicz; Irene Petersen; Irwin Nazareth
Journal:  Br J Psychiatry       Date:  2009-12       Impact factor: 9.319

Review 7.  Genes associated with Parkinson syndrome.

Authors:  Saskia Biskup; Manfred Gerlach; Andreas Kupsch; Heinz Reichmann; Peter Riederer; Peter Vieregge; Ullrich Wüllner; Thomas Gasser
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

8.  Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis.

Authors:  Lisa M Lix; Douglas E Hobson; Mahmoud Azimaee; William D Leslie; Charles Burchill; Shaun Hobson
Journal:  J Epidemiol Community Health       Date:  2009-08-13       Impact factor: 3.710

9.  The importance of defining periods of complete mortality reporting for research using automated data from primary care.

Authors:  Andrew Maguire; Betina T Blak; Mary Thompson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-01       Impact factor: 2.890

10.  Identifying periods of acceptable computer usage in primary care research databases.

Authors:  Laura Horsfall; Kate Walters; Irene Petersen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-11-04       Impact factor: 2.890

View more
  13 in total

1.  Time Trends in the Incidence of Parkinson Disease.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

Review 2.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

3.  The future burden of Parkinson's disease.

Authors:  Walter A Rocca
Journal:  Mov Disord       Date:  2017-08-07       Impact factor: 10.338

4.  Variations in Incidence and Prevalence of Parkinson's Disease in Taiwan: A Population-Based Nationwide Study.

Authors:  Chih-Ching Liu; Chung-Yi Li; Pei-Chen Lee; Yu Sun
Journal:  Parkinsons Dis       Date:  2016-01-19

5.  Socioeconomic status in relation to Parkinson's disease risk and mortality: A population-based prospective study.

Authors:  Fei Yang; Anna L V Johansson; Nancy L Pedersen; Fang Fang; Margaret Gatz; Karin Wirdefeldt
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

6.  Current and projected future economic burden of Parkinson's disease in the U.S.

Authors:  Wenya Yang; Jamie L Hamilton; Catherine Kopil; James C Beck; Caroline M Tanner; Roger L Albin; E Ray Dorsey; Nabila Dahodwala; Inna Cintina; Paul Hogan; Ted Thompson
Journal:  NPJ Parkinsons Dis       Date:  2020-07-09

7.  Post-war (1946-2017) population health change in the United Kingdom: A systematic review.

Authors:  Dawid Gondek; David Bann; Ke Ning; Emily Grundy; George B Ploubidis
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

8.  Entropy of Real-World Gait in Parkinson's Disease Determined from Wearable Sensors as a Digital Marker of Altered Ambulatory Behavior.

Authors:  Lucy Coates; Jian Shi; Lynn Rochester; Silvia Del Din; Annette Pantall
Journal:  Sensors (Basel)       Date:  2020-05-05       Impact factor: 3.847

9.  Parkinson Matters.

Authors:  Sirwan K L Darweesh; Karen G Raphael; Patrik Brundin; Helen Matthews; Richard K Wyse; Honglei Chen; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

10.  Identifying incident Parkinson's disease using administrative diagnostic codes: a validation study.

Authors:  Brett J Peterson; Walter A Rocca; James H Bower; Rodolfo Savica; Michelle M Mielke
Journal:  Clin Park Relat Disord       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.